Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2 4Phase EARLY_PHASE1 2Phase 4 2Phase 1/2 2Phase 3 1

Status

Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 104Carcinoma, Hepatocellular 103Stomach Neoplasms 62Pancreatic Neoplasms 46Liver Neoplasms 38Colonic Neoplasms 37Esophageal Neoplasms 28Rectal Neoplasms 22Neoplasms 13Neoplasm Metastasis 13Gastrointestinal Neoplasms 12Barrett Esophagus 11Recurrence 10Gastrointestinal Stromal Tumors 10Breast Neoplasms 10Bile Duct Neoplasms 10Pain, Postoperative 9Lung Neoplasms 8Cholangiocarcinoma 8Head and Neck Neoplasms 7Malnutrition 6Hepatitis B 6Carcinoma, Non-Small-Cell Lung 6Biliary Tract Neoplasms 6Agnosia 6Adenocarcinoma 6Prostatic Neoplasms 5Postoperative Complications 5Peptic Ulcer 5Pain 5

Interventions

Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Pancreatic Cancer Non-resectable × Gastrointestinal × Clear all
NCT07302841 2025-12-24

Tunlametinib + AG + Cetuximab β as First-Line Therapy for Advanced Pancreatic Cancer

Tianjin Medical University Cancer Institute and Hospital

Phase 4 Not yet recruiting
28 enrolled
Gastrointestinal

Pancreatic Cancer Non-resectable

NCT06387368 2024-04-29

Clinical Study of Huaier Granule in the Treatment of Unresectable Pancreatic Cancer

Xi'an Jiaotong University

Phase 4 Not yet recruiting
488 enrolled
Gastrointestinal

Pancreatic Cancer Non-resectable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡